A detailed history of Charles Schwab Investment Management Inc transactions in Grifols Sa stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 31,543 shares of GRFS stock, worth $229,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,543
Previous 29,242 7.87%
Holding current value
$229,317
Previous $184,000 52.17%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.28 - $9.38 $14,450 - $21,583
2,301 Added 7.87%
31,543 $280,000
Q2 2024

Aug 12, 2024

BUY
$6.27 - $7.7 $183,347 - $225,163
29,242 New
29,242 $184,000
Q4 2023

Feb 06, 2024

BUY
$7.71 - $11.56 $2,914 - $4,369
378 Added 0.78%
48,903 $565,000
Q3 2023

Nov 08, 2023

BUY
$8.91 - $10.91 $62,566 - $76,610
7,022 Added 16.92%
48,525 $443,000
Q2 2023

Aug 09, 2023

BUY
$7.14 - $9.29 $296,331 - $385,562
41,503 New
41,503 $380,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.94B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.